<DOC>
	<DOCNO>NCT00676286</DOCNO>
	<brief_summary>This study use high field MRI ( 3 Tesla ) , PET biomarker follow prostate cancer determine test detect cancer become aggressive .</brief_summary>
	<brief_title>Biological Investigations Active Surveillance ( BIAS ) IGAR 2008 I 19 Prostate Cancer Using High Field MRI ( 3 Tesla ) , PET , Biomarkers</brief_title>
	<detailed_description>This study may lead identification additional investigation monitor sign disease progression active surveillance protocol . This directly benefit patient provide great confidence disease accurately monitor . In addition , study may beneficial general management prostate cancer add knowledge investigation characterize prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Histologically proven adenocarcinoma prostate Registration must occur within 16 week last biopsy History physical exam ( include DRE ) within 8 week prior registration Patients must indolent prostate cancer include follow : Low risk prostate cancer , less equal 50 % core biopsy involve disease , less equal three biopsy involve disease Patients must minimum six biopsy ( sextant ) registration PSA test within 8 week registration Creatinine level 100 umol/L within 8 week registration Patients must contraindications MRI scan No history previous malignancy except nonmelanoma skin tumor malignancy great 5 year life expectancy Patients must reliable follow Patient histologicallyproven adenocarcinoma prostate Last biopsy great 16 week prior registration History physical exam ( include DRE ) great 8 week prior registration Patient indolent disease Patient le six sextant biopsy registration PSA test do great 8 week registration Creatinine level great 100 umol/L within 8 week registration Contraindications MRI scan History previous malignancy nonmelanoma skin tumor malignancy great 5 year life expectancy Patients reliable follow</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Prostate cancer active surveillance</keyword>
	<keyword>3 Tesla MR biological imaging prostate cancer</keyword>
	<keyword>tumor gene re-arrangements prostate cancer</keyword>
</DOC>